1 1115 155 EFFICACY OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN REDUCING STRESS AND INFLAMMATION: PRELIMINARY RESULTS. OBJECTIVES: PREVIOUSLY IT WAS SHOWN THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING OXIDATIVE STRESS AND RISK OF CHRONIC DISEASES EVEN IN A SHORT DURATION. THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING STRESS AND INFLAMMATION IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. DESIGN: THIS STUDY REPORTS PRELIMINARY RESULTS FROM A NONRANDOMIZED PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN. SETTING/LOCATION: THE STUDY WAS CONDUCTED AT THE INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING THESE YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. SUBJECTS: PATIENTS WITH CHRONIC INFLAMMATORY DISEASES AND OVERWEIGHT/OBESE SUBJECTS WERE INCLUDED WHILE PHYSICALLY CHALLENGED, AND THOSE ON OTHER INTERVENTIONS WERE EXCLUDED FROM THE STUDY. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: THERE WAS A REDUCTION IN STRESS (PLASMA CORTISOL AND BETA-ENDORPHIN) AND INFLAMMATION (INTERLEUKIN [IL]-6 AND TUMOR NECROSIS FACTOR [TNF]-ALPHA) AT DAY 0 VERSUS DAY 10. RESULTS: EIGHTY-SIX (86) PATIENTS (44 FEMALE, 42 MALE, 40.07 +/- 13.91 YEARS) ATTENDED THIS PROGRAM. OVERALL, THE MEAN LEVEL OF CORTISOL DECREASED FROM BASELINE TO DAY 10 (149.95 +/- 46.07, 129.07 +/- 33.30 NG/ML; P=0.001) WHILE BETA-ENDORPHINS INCREASED FROM BASELINE TO DAY 10 (3.53 +/- 0.88, 4.06 +/- 0.79 NG/ML; P=0.024). ALSO, THERE WAS REDUCTION FROM BASELINE TO DAY 10 IN MEAN LEVELS OF IL-6 (2.16 +/- 0.42, 1.94 +/- 0.10 PG/ML, P=0.036) AND TNF-ALPHA (2.85 +/- 0.59, 1.95 +/- 0.32 PG/ML, P=0.002). CONCLUSIONS: THIS BRIEF YOGA-BASED LIFESTYLE INTERVENTION REDUCED THE MARKERS OF STRESS AND INFLAMMATION AS EARLY AS 10 DAYS IN PATIENTS WITH CHRONIC DISEASES; HOWEVER, COMPLETE RESULTS OF THIS STUDY WILL CONFIRM WHETHER THIS PROGRAM HAS UTILITY AS COMPLEMENTARY AND ALTERNATIVE THERAPY. 2012 2 1910 35 RISK INDICES ASSOCIATED WITH THE INSULIN RESISTANCE SYNDROME, CARDIOVASCULAR DISEASE, AND POSSIBLE PROTECTION WITH YOGA: A SYSTEMATIC REVIEW. OBJECTIVE: TO CONDUCT A SYSTEMATIC REVIEW OF PUBLISHED LITERATURE REGARDING THE EFFECTS OF YOGA, A PROMISING MIND-BODY THERAPY, ON SPECIFIC ANTHROPOMETRIC AND PHYSIOLOGIC INDICES OF CARDIOVASCULAR DISEASE (CVD) RISK AND ON RELATED CLINICAL ENDPOINTS. METHODS: WE PERFORMED A LITERATURE SEARCH USING 4 COMPUTERIZED ENGLISH AND INDIAN SCIENTIFIC DATABASES. THE SEARCH WAS RESTRICTED TO ORIGINAL STUDIES (1970 TO 2004) EVALUATING THE EFFECTS OF YOGA ON CVD OR INDICES OF CVD RISK ASSOCIATED WITH THE INSULIN RESISTANCE SYNDROME (IRS). RANDOMIZED CONTROLLED TRIALS (RCTS), NONRANDOMIZED CONTROLLED TRIALS, UNCONTROLLED (PRE AND POST) CLINICAL TRIALS, AND CROSS-SECTIONAL (OBSERVATIONAL) STUDIES WERE INCLUDED IF THEY MET SPECIFIC CRITERIA. DATA WERE EXTRACTED REGARDING STUDY DESIGN, SETTING, POPULATION SIZE AND CHARACTERISTICS, INTERVENTION TYPE AND DURATION, COMPARISON GROUP OR CONDITION, OUTCOME ASSESSMENT, DATA ANALYSIS AND PRESENTATION, FOLLOW-UP, AND KEY RESULTS, AND THE QUALITY OF EACH STUDY WAS EVALUATED ACCORDING TO SPECIFIC PREDETERMINED CRITERIA. RESULTS: WE IDENTIFIED 70 ELIGIBLE STUDIES, INCLUDING 1 OBSERVATIONAL STUDY, 26 UNCONTROLLED CLINICAL TRIALS, 21 NONRANDOMIZED CONTROLLED CLINICAL TRIALS, AND 22 RCTS. TOGETHER, THE REPORTED RESULTS OF THESE STUDIES INDICATE BENEFICIAL CHANGES OVERALL IN SEVERAL IRS-RELATED INDICES OF CVD RISK, INCLUDING GLUCOSE TOLERANCE AND INSULIN SENSITIVITY, LIPID PROFILES, ANTHROPOMETRIC CHARACTERISTICS, BLOOD PRESSURE, OXIDATIVE STRESS, COAGULATION PROFILES, SYMPATHETIC ACTIVATION, AND CARDIOVAGAL FUNCTION, AS WELL AS IMPROVEMENT IN SEVERAL CLINICAL ENDPOINTS. CONCLUSIONS: COLLECTIVELY, THESE STUDIES SUGGEST THAT YOGA MAY REDUCE MANY IRS-RELATED RISK FACTORS FOR CVD, MAY IMPROVE CLINICAL OUTCOMES, AND MAY AID IN THE MANAGEMENT OF CVD AND OTHER IRS-RELATED CONDITIONS. HOWEVER, THE METHODOLOGIC AND OTHER LIMITATIONS CHARACTERIZING MOST OF THESE STUDIES PRECLUDE DRAWING FIRM CONCLUSIONS. ADDITIONAL HIGH QUALITY RCTS ARE NEEDED TO CONFIRM AND FURTHER ELUCIDATE THE EFFECTS OF STANDARDIZED YOGA PROGRAMS ON SPECIFIC INDICES OF CVD RISK AND RELATED CLINICAL ENDPOINTS. 2005 3 1188 29 EVIDENCE MAP OF YOGA FOR DEPRESSION, ANXIETY, AND POSTTRAUMATIC STRESS DISORDER. BACKGROUND: THIS STUDY DESCRIBES EVIDENCE OF YOGA'S EFFECTIVENESS FOR DEPRESSIVE DISORDERS, GENERAL ANXIETY DISORDER (GAD), PANIC DISORDER (PD), AND POSTTRAUMATIC STRESS DISORDER (PTSD) IN ADULTS. WE ALSO ADDRESS ADVERSE EVENTS ASSOCIATED WITH YOGA. METHODS: WE SEARCHED MULTIPLE ELECTRONIC DATABASES FOR SYSTEMATIC REVIEWS (SRS) PUBLISHED BETWEEN 2008 AND JULY 2014, RANDOMIZED CONTROLLED TRIALS (RCTS) NOT IDENTIFIED IN ELIGIBLE SRS, AND ONGOING RCTS REGISTERED WITH CLINCALTRIALS.GOV. RESULTS: WE IDENTIFIED 1 SR ON DEPRESSION, 1 FOR ADVERSE EVENTS, AND 3 ADDRESSING MULTIPLE CONDITIONS. THE HIGH-QUALITY DEPRESSION SR INCLUDED 12 RCTS (N = 619) THAT SHOWED IMPROVED SHORT-TERM DEPRESSIVE SYMPTOMS (STANDARDIZED MEAN DIFFERENCE, -0.69, 95% CONFIDENCE INTERVAL, -0.99 TO -0.39), BUT THERE WAS SUBSTANTIAL VARIABILITY (I2 = 86%) AND A HIGH RISK OF BIAS FOR 9 STUDIES. THREE SRS ADDRESSING MULTIPLE CONDITIONS IDENTIFIED 4 NONRANDOMIZED STUDIES (N = 174) FOR GAD/PD AND 1 RCT (N = 8) AND 2 NONRANDOMIZED STUDIES (N = 22) FOR PTSD. WE SEPARATELY FOUND 1 RCT (N = 13) FOR GAD AND 2 RCTS (N = 102) FOR PTSD. COLLECTIVELY, THESE STUDIES WERE INCONCLUSIVE FOR THE EFFECTIVENESS OF YOGA IN TREATING GAD/PD AND PTSD. THE HIGH-QUALITY SR FOR ADVERSE EVENTS INCLUDED 37 PRIMARY REPORTS (N = 76) IN WHICH INVERSION POSTURES WERE MOST OFTEN IMPLICATED. WE FOUND 5 ONGOING TRIALS (3 FOR PTSD). CONCLUSIONS: YOGA MAY IMPROVE SHORT-TERM DEPRESSIVE SYMPTOMS, BUT EVIDENCE FOR GAD, PD, AND PTSD REMAIN INCONCLUSIVE. 2016 4 477 32 CLINICAL APPLICATIONS OF YOGA FOR THE PEDIATRIC POPULATION: A SYSTEMATIC REVIEW. OBJECTIVE: THE AIM OF THIS STUDY WAS TO EVALUATE THE EVIDENCE FOR CLINICAL APPLICATIONS OF YOGA AMONG THE PEDIATRIC POPULATION. METHODS: WE CONDUCTED AN ELECTRONIC LITERATURE SEARCH INCLUDING CINAHL, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), EMBASE, MEDLINE, PSYCINFO, AND MANUAL SEARCH OF RETRIEVED ARTICLES FROM INCEPTION OF EACH DATABASE UNTIL DECEMBER 2008. RANDOMIZED CONTROLLED TRIALS (RCTS) AND NONRANDOMIZED CONTROLLED TRIALS (NRCTS) WERE SELECTED THAT INCLUDED YOGA OR YOGA-BASED INTERVENTIONS FOR INDIVIDUALS AGED 0 TO 21 YEARS. DATA WERE EXTRACTED AND ARTICLES CRITICALLY REVIEWED USING A MODIFIED JADAD SCORE AND DESCRIPTIVE METHODOLOGICAL CRITERIA, WITH SUMMARIZATION IN TABLES. RESULTS: THIRTY-FOUR CONTROLLED STUDIES PUBLISHED FROM 1979 TO 2008 WERE IDENTIFIED, WITH 19 RCTS AND 15 NRCTS. MANY STUDIES WERE OF LOW METHODOLOGICAL QUALITY. CLINICAL AREAS FOR WHICH YOGA HAS BEEN STUDIED INCLUDE PHYSICAL FITNESS, CARDIORESPIRATORY EFFECTS, MOTOR SKILLS/STRENGTH, MENTAL HEALTH AND PSYCHOLOGICAL DISORDERS, BEHAVIOR AND DEVELOPMENT, IRRITABLE BOWEL SYNDROME, AND BIRTH OUTCOMES FOLLOWING PRENATAL YOGA. NO ADVERSE EVENTS WERE REPORTED IN TRIALS REVIEWED. ALTHOUGH A LARGE MAJORITY OF STUDIES WERE POSITIVE, METHODOLOGICAL LIMITATIONS SUCH AS RANDOMIZATION METHODS, WITHDRAWAL/DROPOUTS, AND DETAILS OF YOGA INTERVENTION PRECLUDE CONCLUSIVE EVIDENCE. CONCLUSIONS: THERE ARE LIMITED DATA ON THE CLINICAL APPLICATIONS OF YOGA AMONG THE PEDIATRIC POPULATION. MOST PUBLISHED CONTROLLED TRIALS WERE SUGGESTIVE OF BENEFIT, BUT RESULTS ARE PRELIMINARY BASED ON LOW QUANTITY AND QUALITY OF TRIALS. FURTHER RESEARCH OF YOGA FOR CHILDREN BY USING A HIGHER STANDARD OF METHODOLOGY AND REPORTING IS WARRANTED. 2009 5 674 53 EFFECT OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE IN OVERWEIGHT AND OBESE SUBJECTS. OBJECTIVE: TO STUDY THE EFFECT OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN OVERWEIGHT AND OBESE PERSONS. DESIGN AND SETTING: NONRANDOMIZED, SINGLE-ARM INTERVENTIONAL STUDY CONDUCTED FROM AUGUST 2012 TO MARCH 2015 AT INTEGRAL HEALTH CLINIC, DEPARTMENT OF PHYSIOLOGY, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA. PARTICIPANTS: OVERWEIGHT (BODY-MASS INDEX [BMI], 23-24.9 KG/M(2)) AND OBESE (BMI, >/=25 KG/M(2)) PERSONS (N = 279) AGED 20-60 YEARS. INTERVENTION: PRETESTED YOGA-BASED LIFESTYLE INTERVENTION, INCLUDING ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, LECTURES, GROUP SUPPORT, NUTRITION AWARENESS PROGRAM, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: PRIMARY OUTCOME MEASURE WAS HRQOL, MEASURED BY USING SHORT VERSION OF WORLD HEALTH ORGANIZATION QUALITY OF LIFE (WHOQOL-BREF) QUESTIONNAIRE. SECONDARY OUTCOME MEASURES WERE ANTHROPOMETRIC VARIABLES, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, PULSE RATE, LIPID PROFILE, AND FASTING GLUCOSE. A SUBGROUP ANALYSIS ACCORDING TO SEX WAS ALSO PERFORMED. RESULTS: THE OVERALL QUALITY OF LIFE AND HEALTH IMPROVED AFTER SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT AND OBESE PERSONS. PHYSICAL, PSYCHOLOGICAL AND ENVIRONMENTAL DOMAIN SCORES SIGNIFICANTLY INCREASED FROM BASELINE TO DAY 10, AND EFFICACY WAS NOTED IN BOTH MALE AND FEMALE SUBGROUPS. AFTER 10 DAYS OF INTERVENTION, THE FOLLOWING ALSO DECREASED SIGNIFICANTLY: BODY WEIGHT, BMI, TOTAL BODY FAT, WAIST AND HIP CIRCUMFERENCE, WAIST-TO-HIP RATIO, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN, TRIGLYCERIDES, AND FASTING GLUCOSE. CONCLUSION: A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION HAD A POSITIVE EFFECT ON HRQOL IN OVERWEIGHT AND OBESE PERSONS. 2016 6 284 77 ADIPONECTIN, INTERLEUKIN-6, AND CARDIOVASCULAR DISEASE RISK FACTORS ARE MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT AND OBESE MEN. OBJECTIVE: TO INVESTIGATE THE EFFECT OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON RISK FACTORS FOR CARDIOVASCULAR DISEASE (CVD) AND MARKERS OF INFLAMMATION AND ENDOTHELIAL FUNCTION IN OVERWEIGHT AND OBESE MEN. DESIGN: NONRANDOMIZED PROSPECTIVE LIFESTYLE INTERVENTION STUDY WITH PRE-POST DESIGN. SETTING AND LOCATION: INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY PROVIDING YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. SUBJECTS: OVERWEIGHT AND OBESE MEN (N=51) WERE ENROLLED IN THE STUDY. SUBJECTS WHO WERE PHYSICALLY UNABLE TO PARTICIPATE AND THOSE PARTICIPATING IN OTHER INTERVENTIONS WERE EXCLUDED FROM THE STUDY. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDING ASANAS (PHYSICAL POSTURES), PRANAYAMA (BREATHING EXERCISES), GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: THE PRIMARY OUTCOME MEASURE WAS WEIGHT LOSS, AND THE SECONDARY OUTCOME MEASURES WERE CLINICAL AND LABORATORY CORRELATES OF CVD RISK, LEVELS OF INTERLEUKIN-6 (IL-6), ADIPONECTIN, AND ENDOTHELIN-1 (ET-1). RESULTS: MEN (N=51, BODY MASS INDEX [BMI] 26.26+/-2.42 KG/M(2)) WERE ENROLLED AND UNDERWENT A YOGA-BASED LIFESTYLE INTERVENTION FOR 10 DAYS. OF 51 SUBJECTS, 30 COMPLETED THE STUDY. THERE WAS A SIGNIFICANT REDUCTION IN WEIGHT FROM BASELINE TO DAY 10 (74.60+/-7.98, 72.69+/-8.37 KG, P<0.001, RESPECTIVELY), BMI (26.26+/-2.42, 25.69+/-2.47 KG/M(2), P<0.001, RESPECTIVELY), AND SYSTOLIC BP (121.73+/-11.58, 116.73+/-9.00, P=0.042, RESPECTIVELY). THERE WAS A SIGNIFICANT REDUCTION IN PLASMA IL-6 FROM BASELINE TO DAY 10 (MEDIAN 2.24 VS. 1.26 PG/ML, RESPECTIVELY, P=0.012). THERE WAS A SIGNIFICANT INCREASE IN THE PLASMA ADIPONECTIN FROM BASELINE TO DAY 10 (MEDIAN 4.95 VS. 6.26 MUG/ML, RESPECTIVELY, P=0.014). PLASMA ET-1 LEVEL REMAINED UNCHANGED. CONCLUSION: THESE FINDINGS SUGGEST THAT EVEN A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION MAY BE AN IMPORTANT MODALITY TO REDUCE THE RISK FOR CVD AS INDICATED BY WEIGHT LOSS, REDUCTION IN SYSTOLIC BLOOD PRESSURE, AN INCREASE IN ADIPONECTIN, AND DECREASE IN IL-6 IN OVERWEIGHT AND OBESE MEN. 2013 7 2539 31 YOGA FOR ADULTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW OF CONTROLLED TRIALS. A GROWING BODY OF EVIDENCE SUGGESTS YOGIC PRACTICES MAY BENEFIT ADULTS WITH TYPE 2 DIABETES (DM2). IN THIS SYSTEMATIC REVIEW, WE EVALUATE AVAILABLE EVIDENCE FROM PROSPECTIVE CONTROLLED TRIALS REGARDING THE EFFECTS OF YOGA-BASED PROGRAMS ON SPECIFIC HEALTH OUTCOMES PERTINENT TO DM2 MANAGEMENT. TO IDENTIFY QUALIFYING STUDIES, WE SEARCHED NINE DATABASES AND SCANNED BIBLIOGRAPHIES OF RELEVANT REVIEW PAPERS AND ALL IDENTIFIED ARTICLES. CONTROLLED TRIALS THAT DID NOT TARGET ADULTS WITH DIABETES, INCLUDED ONLY ADULTS WITH TYPE 1 DIABETES, WERE UNDER TWO-WEEK DURATION, OR DID NOT INCLUDE QUANTITATIVE OUTCOME DATA WERE EXCLUDED. STUDY QUALITY WAS EVALUATED USING THE PEDRO SCALE. THIRTY-THREE PAPERS REPORTING FINDINGS FROM 25 CONTROLLED TRIALS (13 NONRANDOMIZED, 12 RANDOMIZED) MET OUR INCLUSION CRITERIA (N = 2170 PARTICIPANTS). COLLECTIVELY, FINDINGS SUGGEST THAT YOGIC PRACTICES MAY PROMOTE SIGNIFICANT IMPROVEMENTS IN SEVERAL INDICES OF IMPORTANCE IN DM2 MANAGEMENT, INCLUDING GLYCEMIC CONTROL, LIPID LEVELS, AND BODY COMPOSITION. MORE LIMITED DATA SUGGEST THAT YOGA MAY ALSO LOWER OXIDATIVE STRESS AND BLOOD PRESSURE; ENHANCE PULMONARY AND AUTONOMIC FUNCTION, MOOD, SLEEP, AND QUALITY OF LIFE; AND REDUCE MEDICATION USE IN ADULTS WITH DM2. HOWEVER, GIVEN THE METHODOLOGICAL LIMITATIONS OF EXISTING STUDIES, ADDITIONAL HIGH-QUALITY INVESTIGATIONS ARE REQUIRED TO CONFIRM AND FURTHER ELUCIDATE THE POTENTIAL BENEFITS OF YOGA PROGRAMS IN POPULATIONS WITH DM2. 2016 8 2523 21 YOGA DURING PREGNANCY: A REVIEW. THE PURPOSE OF THIS REVIEW ARTICLE IS TO EVALUATE THE PERIPARTUM OUTCOMES OF YOGA DURING PREGNANCY, INCLUDING THE POSTPARTUM PERIOD AND LACTATION. THE PUBMED DATABASE WAS ANALYZED FROM JANUARY 1970 TO JANUARY 2011. WE IDENTIFIED FIVE PROSPECTIVE OBSERVATIONAL STUDIES (N = 575) AND THREE RANDOMIZED CLINICAL TRIALS (RCTS; N = 298), WHICH WERE ANALYZED SEPARATELY. THE NONRANDOMIZED TRIALS INDICATED A SIGNIFICANT REDUCTION IN RATES OF PRETERM LABOR (P < 0.0006), INTRAUTERINE GROWTH RETARDATION (P <0.003), LOW BIRTH WEIGHT (P < 0.01), PREGNANCY DISCOMFORTS (P = 0.01), AND PERCEIVED SLEEP DISTURBANCES (P = 0.03) IN THOSE WHO PRACTICED YOGA DURING PREGNANCY. RESULTS OF THE RCTS INDICATED THAT DOING YOGA DURING PREGNANCY CAN SIGNIFICANTLY LOWER PAIN AND DISCOMFORT (P < 0.05) AND PERCEIVED STRESS (P = 0.001) AND IMPROVE QUALITY OF LIFE IN PHYSICAL DOMAINS (P = 0.001). ALL THREE RCTS WERE POORLY COMPLIANT WITH THE CONSOLIDATED STANDARD OF REPORTING TRIALS STATEMENT. WHILE AWAITING AN APPROPRIATELY DESIGNED RCT TO DETERMINE THE BENEFITS OF YOGA DURING PREGNANCY, IT REMAINS A VIABLE EXERCISE OPTION. 2012 9 2024 25 SYSTEMATIC REVIEW OF YOGA INTERVENTIONS FOR ANXIETY REDUCTION AMONG CHILDREN AND ADOLESCENTS. OBJECTIVE: ANXIETY DISORDERS ARE THE MOST PREVALENT PSYCHOLOGICAL DISORDERS AMONG CHILDREN AND YOUTHS. THERE IS GROWING INTEREST IN INTERVENTION OPTIONS FOR ANXIETY. YOGA IS WIDELY USED IN CLINICAL, SCHOOL, AND COMMUNITY SETTINGS, BUT CONSOLIDATED SOURCES OUTLINING ITS EFFECTIVENESS IN REDUCING ANXIETY ARE LIMITED. METHOD: THIS SYSTEMATIC REVIEW EXAMINED THE EVIDENCE BASE (1990-2014) FOR YOGA INTERVENTIONS ADDRESSING ANXIETY AMONG CHILDREN AND ADOLESCENTS (AGES 3-18 YR). RESULTS: WE IDENTIFIED 2,147 REFERENCES AND FOUND 80 ARTICLES THAT WERE ELIGIBLE FOR FULL-TEXT REVIEW. THE FINAL ANALYSIS INCLUDED 16: 6 RANDOMIZED CONTROLLED TRIALS, 2 NONRANDOMIZED PREINTERVENTION-POSTINTERVENTION CONTROL-GROUP DESIGNS, 7 UNCONTROLLED PREINTERVENTION-POSTINTERVENTION STUDIES, AND 1 CASE STUDY. CONCLUSION: NEARLY ALL STUDIES INDICATED REDUCED ANXIETY AFTER A YOGA INTERVENTION. HOWEVER, BECAUSE OF THE WIDE VARIETY OF STUDY POPULATIONS, LIMITATIONS IN SOME STUDY DESIGNS, AND VARIABLE OUTCOME MEASURES, FURTHER RESEARCH IS NEEDED TO ENHANCE THE ABILITY TO GENERALIZE AND APPLY YOGA TO REDUCE ANXIETY. 2015 10 1064 27 EFFECTS OF YOGA ON IMMUNE FUNCTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. OBJECTIVE: THIS SYSTEMATIC REVIEW ATTEMPTS TO CONFIRM THE ADDED EVIDENCE TO ASSESS THE EFFECT OF YOGA ON IMMUNE FUNCTION. METHODS: THE COCHRANE LIBRARY, EMBASE, PSYCINFO, PUBMED, AND WEB OF SCIENCE ELECTRONIC DATABASES WERE SEARCHED ACCORDING TO THE PRISRMA METHOD TO IDENTIFY RANDOMIZED CONTROLLED TRIALS (RCTS) ON THE IMMUNOLOGICAL EFFECTS OF YOGA PUBLISHED IN THE ENGLISH LANGUAGE FROM JANUARY 1, 2017, TO DECEMBER 31, 2020. THIS REVIEW COULD ONLY BE DESCRIPTIVELY SUMMARIZED BECAUSE OF HETEROGENEITY OF THE INCLUDED RCTS. RESULTS: ELEVEN POTENTIAL TRIALS WERE IDENTIFIED AND INCLUDED IN THIS REVIEW. QUALITY APPRAISAL OF INCLUDED TRIALS RANGED FROM 3 FOR UNCLEAR RISK OF BIAS AND 8 FOR HIGH RISK OF BIAS. THERE IS EVIDENCE FROM 11 RCTS THAT YOGA MAY HAVE FAVORABLE EFFECTS FOR REDUCING THE LEVELS OF ANTI-INFLAMMATORY MARKERS. CONCLUSIONS: YOGA MAY BE USED AS A COMPLEMENTARY INTERVENTION FOR CLINICAL POPULATIONS OR HEALTHY INDIVIDUALS. 2021 11 2245 35 THE INFLUENCE OF YOGA-BASED PROGRAMS ON RISK PROFILES IN ADULTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW. THERE IS GROWING EVIDENCE THAT YOGA MAY OFFER A SAFE AND COST-EFFECTIVE INTERVENTION FOR TYPE 2 DIABETES MELLITUS (DM 2). HOWEVER, SYSTEMATIC REVIEWS ARE LACKING. THIS ARTICLE CRITICALLY REVIEWS THE PUBLISHED LITERATURE REGARDING THE EFFECTS OF YOGA-BASED PROGRAMS ON PHYSIOLOGIC AND ANTHROPOMETRIC RISK PROFILES AND RELATED CLINICAL OUTCOMES IN ADULTS WITH DM 2. WE PERFORMED A COMPREHENSIVE LITERATURE SEARCH USING FOUR COMPUTERIZED ENGLISH AND INDIAN SCIENTIFIC DATABASES. THE SEARCH WAS RESTRICTED TO ORIGINAL STUDIES (1970-2006) THAT EVALUATED THE METABOLIC AND CLINICAL EFFECTS OF YOGA IN ADULTS WITH DM 2. STUDIES TARGETING CLINICAL POPULATIONS WITH CARDIOVASCULAR DISORDERS THAT INCLUDED ADULTS WITH COMORBID DM WERE ALSO EVALUATED. DATA WERE EXTRACTED REGARDING STUDY DESIGN, SETTING, TARGET POPULATION, INTERVENTION, COMPARISON GROUP OR CONDITION, OUTCOME ASSESSMENT, DATA ANALYSIS AND PRESENTATION, FOLLOW-UP, AND KEY RESULTS, AND THE QUALITY OF EACH STUDY WAS EVALUATED ACCORDING TO SPECIFIC PREDETERMINED CRITERIA. WE IDENTIFIED 25 ELIGIBLE STUDIES, INCLUDING 15 UNCONTROLLED TRIALS, 6 NON-RANDOMIZED CONTROLLED TRIALS AND 4 RANDOMIZED CONTROLLED TRIALS (RCTS). OVERALL, THESE STUDIES SUGGEST BENEFICIAL CHANGES IN SEVERAL RISK INDICES, INCLUDING GLUCOSE TOLERANCE AND INSULIN SENSITIVITY, LIPID PROFILES, ANTHROPOMETRIC CHARACTERISTICS, BLOOD PRESSURE, OXIDATIVE STRESS, COAGULATION PROFILES, SYMPATHETIC ACTIVATION AND PULMONARY FUNCTION, AS WELL AS IMPROVEMENT IN SPECIFIC CLINICAL OUTCOMES. YOGA MAY IMPROVE RISK PROFILES IN ADULTS WITH DM 2, AND MAY HAVE PROMISE FOR THE PREVENTION AND MANAGEMENT OF CARDIOVASCULAR COMPLICATIONS IN THIS POPULATION. HOWEVER, THE LIMITATIONS CHARACTERIZING MOST STUDIES PRECLUDE DRAWING FIRM CONCLUSIONS. ADDITIONAL HIGH-QUALITY RCTS ARE NEEDED TO CONFIRM AND FURTHER ELUCIDATE THE EFFECTS OF STANDARDIZED YOGA PROGRAMS IN POPULATIONS WITH DM 2. 2007 12 1139 22 EFFICACY OF YOGA TRAINING IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES: TO EVALUATE THE IMPACT OF YOGA TRAINING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). METHOD: A LITERATURE SEARCH WAS PERFORMED IN PUBMED, COCHRANE LIBRARY, EMBASE, CINAHL, AND WEB OF SCIENCE FOR RELEVANT STUDIES PUBLISHED BEFORE JUNE 2017. QUALITY ASSESSMENT, SENSITIVITY ANALYSIS AND HETEROGENEITY WERE PERFORMED. STATA12.0 SOFTWARE WAS USED FOR STATISTICAL ANALYSIS. RESULTS: TEN STUDIES WERE ELIGIBLE FOR THIS ANALYSIS. THERE WERE SIGNIFICANTLY GREATER IMPROVEMENTS IN 6MWD (P = 0.000), BORG SCALE SCORES (P = 0.018), FEV1 VALUE (P = 0. 013), PACO2 (P = 0.037), SGRQ SCORES (P = 0. 000) AND CAT SCORES (P = 0.009) IN YOGA TRAINING PATIENTS. NO STATISTICALLY SIGNIFICANT DIFFERENCE WAS OBSERVED IN THE FEV1/FVC (P = 0.75), FEV1 PREDICTED VALUE (P = 0.057) AND FVC (P = 0.05). CONCLUSIONS: THIS META-ANALYSIS INDICATES THAT YOGA TRAINING CAN BE AN ACCEPTABLE AND APPROPRIATED ADJUNCTIVE REHABILITATION PROGRAM FOR COPD PATIENTS. 2018 13 2585 23 YOGA FOR HYPERTENSION: A SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS. OBJECTIVES: TO CRITICALLY EVALUATE THE EFFECTIVENESS OF YOGA AS A TREATMENT OF HYPERTENSION. METHODS: SEVENTEEN DATABASES WERE SEARCHED FROM THEIR INCEPTIONS TO JANUARY 2014. RANDOMIZED CLINICAL TRIALS (RCTS) WERE INCLUDED, IF THEY EVALUATED YOGA AGAINST ANY TYPE OF CONTROL IN PATIENTS WITH ANY FORM OF ARTERIAL HYPERTENSION. RISK OF BIAS WAS ESTIMATED USING THE COCHRANE CRITERIA. THREE INDEPENDENT REVIEWERS PERFORMED THE SELECTION OF STUDIES, DATA EXTRACTION, AND QUALITY ASSESSMENTS. RESULTS: SEVENTEEN TRIALS MET THE INCLUSION CRITERIA. ONLY TWO RCTS WERE OF ACCEPTABLE METHODOLOGICAL QUALITY. ELEVEN RCTS SUGGESTED THAT YOGA LEADS TO A SIGNIFICANTLY GREATER REDUCTION IN SYSTOLIC BLOOD PRESSURE (SBP) COMPARED TO VARIOUS FORMS OF PHARMACOTHERAPY, BREATH AWARENESS OR READING, HEALTH EDUCATION, NO TREATMENT (NT), OR USUAL CARE (UC). EIGHT RCTS SUGGESTED THAT YOGA LEADS TO A SIGNIFICANTLY GREATER REDUCTION IN DIASTOLIC BLOOD PRESSURE (DBP) OR NIGHT-TIME DBP COMPARED TO PHARMACOTHERAPY, NT, OR UC. FIVE RCTS INDICATED THAT YOGA HAD NO EFFECT ON SBP COMPARED TO DIETARY MODIFICATION (DIM), ENHANCED UC, PASSIVE RELAXATION (PR), OR PHYSICAL EXERCISES (PE). EIGHT RCTS INDICATED THAT YOGA HAD NO EFFECT ON DBP COMPARED TO DIM, ENHANCED UC, PHARMACOTHERAPY, NT, PE, PR, OR BREATH AWARENESS OR READING. ONE RCT DID NOT REPORT BETWEEN-GROUP COMPARISONS. CONCLUSION: THE EVIDENCE FOR THE EFFECTIVENESS OF YOGA AS A TREATMENT OF HYPERTENSION IS ENCOURAGING BUT INCONCLUSIVE. FURTHER, MORE RIGOROUS TRIALS SEEM WARRANTED. 2014 14 2593 26 YOGA FOR MENSTRUAL PAIN IN PRIMARY DYSMENORRHEA: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. OBJECTIVES: TO ASSESS THE OVERALL EFFECT SIZE OF THE IMPACT OF YOGA ON MENSTRUAL PAIN IN PRIMARY DYSMENORRHEA. METHODS: RANDOMIZED CONTROLLED TRIALS THAT WERE PUBLISHED IN THE ENGLISH LANGUAGE UNTIL DECEMBER 2018 IN PUBMED, EMBASE, WEB OF SCIENCE, AND THE COCHRANE LIBRARY ELECTRONIC DATABASES WERE SEARCHED. THE METHODOLOGIES FROM 4 TRIALS CONDUCTED ON 230 PARTICIPANTS WITH PRIMARY DYSMENORRHEA WERE INCLUDED IN THIS META-ANALYSIS TO COMPARE THE EFFECTS THAT PERFORMING A YOGA PROGRAM HAS ON MENSTRUAL PAIN (N=129) TO THE EFFECTS OF NOT PERFORMING YOGA (N=101). RESULTS: THE OVERALL EFFECT SIZE OF THE IMPACT OF A YOGA PROGRAM ON MENSTRUAL PAIN IN PRIMARY DYSMENORRHEA WAS HIGH WITH A STANDARDIZED MEAN DIFFERENCE OF -2.09 (-3.99 TO -0.19) (P=0.031) AMONG THE EFFECT SIZES OF THE 4 TRIALS (95% CONFIDENCE INTERVAL). CONCLUSIONS: YOGA IS AN EFFECTIVE INTERVENTION FOR ALLEVIATING MENSTRUAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHEA. 2019 15 2178 25 THE EFFECTS OF YOGA ON PAIN, MOBILITY, AND QUALITY OF LIFE IN PATIENTS WITH KNEE OSTEOARTHRITIS: A SYSTEMATIC REVIEW. OBJECTIVE. TO SYSTEMATICALLY ASSESS THE EFFECTS OF YOGA ON PAIN, MOBILITY, AND QUALITY OF LIFE IN PATIENTS WITH KNEE OSTEOARTHRITIS. METHODS. PUBMED, MEDLINE, EMBASE, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO), AND OTHER SOURCES WERE SEARCHED SYSTEMATICALLY IN THIS STUDY. TWO REVIEWERS IDENTIFIED ELIGIBLE STUDIES AND EXTRACTED DATA INDEPENDENTLY. DOWNS AND BLACK'S QUALITY INDEX WERE USED TO EVALUATE THE METHODOLOGICAL QUALITY OF THE INCLUDED STUDIES. RESULTS. A TOTAL OF 9 ARTICLES (6 STUDIES) INVOLVING 372 PATIENTS WITH KNEE OSTEOARTHRITIS MET THE INCLUSION CRITERIA. THE MOST COMMON YOGA PROTOCOL IS 40~90 MINUTES/SESSION, LASTING FOR AT LEAST 8 WEEKS. THE EFFECT OF YOGA ON PAIN RELIEF AND FUNCTION IMPROVEMENT COULD BE SEEN AFTER TWO-WEEK INTERVENTION. CONCLUSION. THIS SYSTEMATIC REVIEW SHOWED THAT YOGA MIGHT HAVE POSITIVE EFFECTS IN RELIEVING PAIN AND MOBILITY ON PATIENTS WITH KOA, BUT THE EFFECTS ON QUALITY OF LIFE (QOL) ARE UNCLEAR. BESIDES, MORE OUTCOME MEASURE RELATED TO MENTAL HEALTH OF YOGA EFFECTS ON PEOPLE WITH KOA SHOULD BE CONDUCTED. 2016 16 1059 32 EFFECTS OF YOGA ON EXERCISE CAPACITY IN PATIENTS WITH LYMPHANGIOLEIOMYOMATOSIS: A NONRANDOMIZED CONTROLLED STUDY. OBJECTIVE: TO EVALUATE THE EFFECTS OF YOGA ON EXERCISE CAPACITY AND QUALITY OF LIFE IN PATIENTS WITH LYMPHANGIOLEIOMYOMATOSIS (LAM), A RARE CYSTIC LUNG DISEASE IN WOMEN. PATIENTS AND METHODS: THIS WAS A NONRANDOMIZED, CONTROLLED STUDY CONDUCTED IN BEIJING, CHINA (AUGUST 27, 2017 - APRIL 26, 2018). TWENTY-SIX PARTICIPANTS WERE ALLOCATED TO THE INTERVENTION (YOGA) GROUP (N = 13) OR CONTROL GROUP (N = 13). THE YOGA INTERVENTION INVOLVED A 24-WEEK PROGRAM OF YOGA CLASS TRAINING FOR 90 MIN ONCE A WEEK AND NO FEWER THAN 2 AT-HOME SESSIONS PER WEEK (AT LEAST 15 MIN PER SESSION). THE 6-MIN WALKING DISTANCE (6MWD), LUNG FUNCTION, SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR-D (VEGF-D) LEVELS, QUALITY OF LIFE, AND SYMPTOMS OF ANXIETY AND DEPRESSION WERE MEASURED AT BASELINE, 12-WEEK AND 24-WEEK FOLLOW-UP. AN INCREMENTAL CARDIOPULMONARY EXERCISE TEST WAS CONDUCTED AT BASELINE AND THE 24-WEEK FOLLOW-UP. RESULTS: ELEVEN PATIENTS COMPLETED THE YOGA TRAINING PROGRAM. THE YOGA GROUP EXHIBITED IMPROVEMENTS IN THE FOLLOWING OUTCOMES VERSUS THOSE OF THE CONTROL GROUP: 6MWD (+ 55 +/- 29 M VS + 18 +/- 49 M, P = 0.04), ANAEROBIC THRESHOLD (3.4 +/- 2.4 ML/MIN/KG VS 1.6 +/- 1.4 ML/MIN/KG, P = 0.035) AND PEAK WORK LOAD (11.7 +/- 14.6 W VS 0.2 +/- 9.1 W, P = 0.027). THERE WAS NO SIGNIFICANT DIFFERENCE IN PEAK OXYGEN CONSUMPTION (VO2PEAK), LUNG FUNCTION, VEGF-D LEVEL, AND QUALITY OF LIFE BETWEEN THE YOGA AND CONTROL GROUPS. NO ADVERSE EFFECTS WERE FOUND IN THE YOGA GROUP. CONCLUSION: YOGA IS A FEASIBLE AND SAFE INTERVENTION FOR PULMONARY REHABILITATION AND POTENTIALLY IMPROVES EXERCISE CAPACITY IN PATIENTS WITH LAM. TRIAL REGISTRATION: (CLINICAL TRIAL REGISTRATION NUMBER AT WWW.CHICTR.ORG.CN: CHICTR-OON-1701274). 2020 17 1055 23 EFFECTS OF YOGA ON CHRONIC NECK PAIN: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. [PURPOSE] THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF CHRONIC NECK PAIN. [SUBJECTS AND METHODS] FIVE ELECTRONIC DATABASES WERE SEARCHED TO IDENTIFY RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA INTERVENTION ON CHRONIC NECK PAIN. THE TRIALS WERE PUBLISHED IN THE ENGLISH LANGUAGE BETWEEN JANUARY 1966 AND DECEMBER 2015. THE COCHRANE RISK OF BIAS TOOL WAS USED TO ASSESS THE QUALITY OF THE TRIALS. [RESULTS] THREE TRIALS WERE IDENTIFIED AND INCLUDED IN THIS REVIEW. A CRITICAL APPRAISAL WAS PERFORMED ON THE TRIALS, AND THE RESULT INDICATED A HIGH RISK OF BIAS. A NARRATIVE DESCRIPTION WAS PROCESSED BECAUSE OF THE SMALL NUMBER OF RCTS. NECK PAIN INTENSITY AND FUNCTIONAL DISABILITY WERE SIGNIFICANTLY LOWER IN THE YOGA GROUPS THAN IN THE CONTROL GROUPS. [CONCLUSION] EVIDENCE FROM THE 3 RANDOMLY CONTROLLED TRIALS SHOWS THAT YOGA MAY BE BENEFICIAL FOR CHRONIC NECK PAIN. THE LOW-QUALITY RESULT OF THE CRITICAL APPRAISAL AND THE SMALL NUMBER OF TRIALS SUGGEST THAT HIGH-QUALITY RCTS ARE REQUIRED TO EXAMINE FURTHER THE EFFECTS OF YOGA INTERVENTION ON CHRONIC NECK PAIN RELIEF. 2016 18 2439 27 YOGA AND QUALITY OF LIFE IN WOMEN WITH PRIMARY DYSMENORRHEA: A SYSTEMATIC REVIEW. INTRODUCTION: PRIMARY DYSMENORRHEA IS A PREVALENT CONDITION CAUSING QUALITY OF LIFE (QOL) REDUCTION FOR MANY WOMEN, RESULTING FROM PAIN AS WELL AS PARALLEL SOCIAL AND PSYCHOLOGICAL DISTRESS. YOGA REDUCES PAIN AND SYMPATHETIC REACTIVITY, THUS PROMOTING QOL. THIS ARTICLE REPORTS A SYSTEMATIC REVIEW OF THE EVIDENCE FOR THE EFFECTIVENESS OF YOGA AS A QOL IMPROVEMENT METHOD FOR WOMEN WITH PRIMARY DYSMENORRHEA. METHODS: THE PRISMA GUIDELINES WERE USED IN PREPARATION OF THIS REVIEW. OVID MEDLINE, PSYCINFO, CINAHL, SCOPUS, PUBMED, SCIENCEDIRECT, COCHRANE DATABASE OF SYSTEMATIC REVIEWS (CDSR), AND COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL) WERE SCREENED THROUGH JANUARY 2017 USING THE KEYWORDS YOGA, MEDITATION, MENSTRUAL CYCLE, DYSMENORRHEA, PELVIC PAIN, AND PROSTAGLANDINS. ENGLISH-LANGUAGE RANDOMIZED CONTROLLED TRIALS (RCTS) AND QUASI-EXPERIMENTAL STUDIES REGARDING YOGA, PRIMARY DYSMENORRHEA, AND QOL WERE ELIGIBLE; ALL YOGA STYLES WERE INCLUDED. TWO INDEPENDENT REVIEWERS RATED THE METHODOLOGICAL QUALITY OF EACH STUDY SELECTED FOR REVIEW USING THE DOWNS AND BLACK CHECKLIST; POSSIBLE SCORES RANGED FROM 0 TO 32. RATINGS WERE ESTABLISHED THROUGH CONSENSUS. RESULTS: THE SEARCH YIELDED A TOTAL OF 378 ARTICLES, OF WHICH 14 (AGE RANGE 13-45 YEARS, N = 1409) MET THE CRITERIA FOR FINAL REVIEW: 8 RCTS AND 6 QUASI-EXPERIMENTAL STUDIES. DOWNS AND BLACK RATINGS WERE PREDOMINANTLY MODERATE IN QUALITY WITH MODERATE RISK OF BIAS, RANGING FROM 15 TO 23 (RCTS) AND 10 TO 17 (QUASI-EXPERIMENTAL STUDIES). STATISTICALLY SIGNIFICANT IMPROVEMENTS ALONG MOST QOL DOMAINS, INCLUDING PHYSICAL PAIN, SLEEP, CONCENTRATION, NEGATIVE FEELINGS, SOCIAL RELATIONSHIPS, WORK CAPACITY, AND OVERALL QOL, WERE IDENTIFIED AFTER A YOGA INTERVENTION. RESULTS INDICATE PRELIMINARY EVIDENCE FOR YOGA AS A SAFE AND EFFECTIVE QOL IMPROVEMENT METHOD FOR WOMEN WITH PRIMARY DYSMENORRHEA. DISCUSSION: PRACTITIONERS MAY CONSIDER YOGA FOR MANAGEMENT OF PRIMARY DYSMENORRHEA. HOWEVER, FUTURE RESEARCH USING LARGER RCTS OF HIGH METHODOLOGICAL QUALITY IS NEEDED TO ASCERTAIN THE MAGNITUDE OF YOGA'S CLINICAL SIGNIFICANCE. 2018 19 236 29 A SYSTEMATIC REVIEW: THE EFFECTS OF YOGA ON PREGNANCY. OBJECTIVE: A SYSTEMATIC REVIEW WAS CONDUCTED TO UPDATE AND PROVIDE A COMPREHENSIVE OVERVIEW ON THE PSYCHOLOGICAL EFFECTS OF ANTENATAL YOGA ON PREGNANCY COMPARED TO STANDARD PRENATAL CARE. STUDY DESIGN: FOUR DATABASES WERE SEARCHED USING KEYWORDS "YOGA", "PREGNANCY", "PERINATAL CARE", "PRENATAL CARE", "POSTNATAL CARE", "POSTPARTUM PERIOD", "PERIPARTUM PERIOD", "PATIENT OUTCOME ASSESSMENT", "OUTCOME ASSESSMENT", "PREGNANCY OUTCOME", "TREATMENT OUTCOME". TRIALS WERE CONSIDERED IF THEY WERE RANDOMIZED CONTROLLED TRIALS (RCTS) PUBLISHED FROM 2011 TO 2018 AND EVALUATED AN ANTENATAL YOGA INTERVENTION. ALL STUDIES WERE ASSESSED FOR RISK OF BIAS USING THE COCHRANE CRITERIA. TRIAL CHARACTERISTICS AND OUTCOMES WERE EXTRACTED AND SYNTHESIZED DESCRIPTIVELY WHERE POSSIBLE. DUE TO HETEROGENEITY, META-ANALYSIS WAS NOT POSSIBLE. RESULTS: OF THE 175 NON-DUPLICATED STUDIES, 16 MET CRITERIA FOR FULL-TEXT REVIEW. FIVE RCTS MET THE INCLUSION CRITERIA AND WERE INCLUDED IN THE SYSTEMATIC REVIEW. THE FINDINGS OF THE RCTS SUGGEST ANTENATAL YOGA MAY BE SAFE AND MAY EFFECTIVELY DECREASE STRESS LEVELS, ANXIETY SCORES, DEPRESSION SCORES, AND PAIN RESPONSE AS WELL AS INCREASING MATERNAL IMMUNITY AND EMOTIONAL-WELLBEING. CONCLUSION: YOGA APPEARS TO BE SAFE AND MAY IMPROVE PSYCHOLOGICAL AND PREGNANCY OUTCOMES. HOWEVER, DUE TO THE LIMITED NUMBER OF STUDIES, MORE HIGH-QUALITY, LARGE RCTS ARE NEEDED TO DRAW CONCLUSIONS ABOUT IMPROVEMENT IN OTHER PREGNANCY OUTCOMES. 2020 20 231 26 A SYSTEMATIC REVIEW OF YOGA FOR HEART DISEASE. BACKGROUND: THIS SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS (RCTS) AIMED TO EVALUATE THE QUALITY OF EVIDENCE AND THE STRENGTH OF RECOMMENDATION FOR YOGA AS AN ANCILLARY INTERVENTION FOR HEART DISEASE. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, AND INDMED WERE SEARCHED UP TO OCTOBER 2013. MAIN OUTCOME MEASURES WERE MORTALITY, NONFATAL CARDIAC EVENTS, EXERCISE CAPACITY, HEALTH-RELATED QUALITY OF LIFE, AND MODIFIABLE CARDIAC RISK FACTORS. RISK OF BIAS, QUALITY OF EVIDENCE, AND THE STRENGTH OF THE RECOMMENDATION FOR OR AGAINST YOGA WERE ASSESSED ACCORDING TO THE COCHRANE COLLABORATION AND GRADE RECOMMENDATIONS. RESULTS: SEVEN RCTS WITH 624 PATIENTS COMPARING YOGA TO USUAL CARE WERE INCLUDED. FOR CORONARY HEART DISEASE (FOUR RCTS), THERE WAS VERY LOW EVIDENCE FOR NO EFFECT ON MORTALITY, FOR A REDUCED NUMBER OF ANGINA EPISODES, AND FOR INCREASED EXERCISE CAPACITY, AND LOW EVIDENCE FOR REDUCED MODIFIABLE CARDIAC RISK FACTORS. FOR HEART FAILURE (TWO RCTS), THERE WAS VERY LOW EVIDENCE FOR NO EFFECT ON MORTALITY, AND LOW EVIDENCE FOR INCREASED EXERCISE CAPACITY, AND FOR NO EFFECT ON HEALTH-RELATED QUALITY OF LIFE. FOR CARDIAC DYSRHYTHMIAS TREATED WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ONE RCT), THERE WAS VERY LOW EVIDENCE FOR NO EFFECT ON MORTALITY, AND FOR IMPROVED QUALITY, AND LOW EVIDENCE FOR EFFECTS ON NONFATAL DEVICE-TREATED VENTRICULAR EVENTS. THREE RCTS REPORTED SAFETY DATA AND REPORTED THAT NO ADVERSE EVENTS OCCURRED. CONCLUSIONS: BASED ON THE RESULTS OF THIS REVIEW, WEAK RECOMMENDATIONS CAN BE MADE FOR THE ANCILLARY USE OF YOGA FOR PATIENTS WITH CORONARY HEART DISEASE, HEART FAILURE, AND CARDIAC DYSRHYTHMIA AT THIS POINT. 2015